M&A NEWS

Novosense buys control of radar chip designer Ningbo Gekong for RMB487m

The STAR Market analogue chipmaker is adding microwave and millimetre-wave radar sensors to its automotive and smart-sensing line-up.

M&A News deals deskTechnology / Semiconductors · China, Asia-Pacific16 Nov 2026

Suzhou Novosense Microelectronics Co., Ltd. said on 16 November 2026 that it would pay RMB486.9m in cash for 78.152% of Ningbo Gekong Intelligent Technology Co., Ltd., a designer of microwave and millimetre-wave radar sensor chips, making it a controlling subsidiary.

Why Suzhou Novosense Microelectronics Co., Ltd. (688052.SS) is buying Ningbo Gekong Intelligent Technology Co., Ltd. (78.152%)

Novosense said the deal fills a gap in its radar sensor chip range and helps it move from single chips towards multi-product and system-level solutions in automotive electronics and smart sensing. It plans to combine Gekong's radar expertise with its own sensor, power management, signal chain and radar SoC capabilities and to cross-sell to both companies' customers.

Deal terms and financing

Novosense signed separate agreements with 22 shareholders, including founders Lin Letai and Lin Lejia, Intel Asia-Pacific R&D and a Xiaomi-backed industry fund, with prices differentiated by each seller's entry stage. The total is based on a Shanghai Orient Appraisal valuation of RMB635m for all of Gekong's equity as at 30 April 2026, a 268% uplift on book value, after the carve-out of module subsidiary Nanjing Gransby. There is no profit guarantee, and the core team retains the remaining shares.

Regulatory approvals and timing

The transaction was approved by Novosense's board on 16 November and requires no shareholder vote. It is not a related-party transaction or a major asset restructuring; completion of the share transfers and business registration remains outstanding.

Market context

Founded in 2017, Gekong has volume production of 5.8GHz, 10.5GHz, 24GHz and 60GHz radar chips used in smart lighting, home appliances, security and industrial control. It remains loss-making, reporting a net loss of RMB14.3m on revenue of RMB34.6m for January to April 2026.

More China M&A news

All China deals →